Glycoclear Technology, a new transformative technology for skincare, developed by the founders of IIT Delhi Startup Sanfe, Archit Agarwal and Harry Sehrawat, can potentially revolutionize body care products. Sanfeon Feb 8 launched this revolutionary Glycoclear Technology with one of the largest body care range.
At the core of this transformative technology lies the Glycoclear Complex, an intricate blend of AHAs (alpha-hydroxy acids), and BHAs (beta-hydroxy acids). It is a breakthrough innovation, which is proven for maintaining low pH – exfoliating the skin’s top layer from its very first use, accelerated penetration of actives – making it 3X quick in action and providing instant nourishment to skin making it smoother than ever.
Harry Sehrawat, Co-Founder of Sanfe, expresses, “Glycoclear is more than just a skincare solution, it’s about breaking free from body concerns and societal norms. Each product is designed not just for effectively solving skin concerns but to instil confidence and liberation in every woman.”
Glycoclear Technology has been granted a trademark, solidifying its position as a pioneer in skincare innovation. The Technology range encompasses 18 products, each dermatologist-approved, and subjected to skin safety tests. From addressing keratosis pilaris to targeting skin discoloration, every product is a testament to Sanfe’s dedication to providing specialised solutions tailored to boost women’s confidence and well-being.
Sanfe’s dedication to innovation is underscored by its financial commitment, with an audited turnover of INR 47.5 CR for FY 2022-23, a significant increase from INR 25.5 CR in FY 2021-22. The company allocates 5% of its turnover to research and innovation, aiming for a colossal target of achieving INR 500 CR in the next 3 years, representing a remarkable 500% growth in 2-3 years.
